Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Vote In favor of Your Favored Kind Of Attire - 2Fossil analysis changes what paleontologists know about how long T. rex took to grow full size
- 3Katz, IDF: We assassinated IRGC intelligence chief Majid Khademi
- 4Family-Accommodating Snow Sports Experiences
- 5Iran war drives global fertilizer prices up, raising food cost fears
- Trouvez La Carte De Cr\u00e9dit Id\u00e9ale Pour Vos Besoins En Belgique
- Giant ‘toothed’ birds flew over Antarctica 40 million to 50 million years ago
- Extraordinary Picks for Home Apparatuses: Making Life Simpler
- The 10 Most Noteworthy Games in History
- Falcon 9 rocket launches Starlink satellites before making 550th SpaceX landing (video)
- The most effective method to Comprehend the Variables Affecting Medical attendant Pay rates
- 6 Shades Brands For Seniors
- The Developing Nearby Food Development and Its Advantages
- Study finds humans were making fire 400,000 years ago, far earlier than once thought
